New UK drug approval pathway benefits industry over patients, argues expert
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ. The pathway aligns regulatory review by the Medicines and Healthcare ...
4 hours ago
0
0









